In terms of revenue, the global epilepsy devices market was valued at $611.26 million in 2021, and is expected to reach $1203.70 million by 2030, growing at a CAGR of 7.83% during the forecast period.

GLOBAL EPILEPSY DEVICES MARKET FORECAST 2022-2030

Global Epilepsy Devices Market by Product Type (Conventional Devices, Wearable Devices, Implantable Devices) Market by Technology (Vagus Nerve Stimulation, Deep Brain Stimulation, Accelerometry, Responsive Neurostimulation) Market by Detection & Prediction Devices Type (Electroencephalogram, Intracranial Eeg, Surface Electromyography, Electrocardiography, Video Detection Systems, Electrodermal Activity, Implanted Advisory Systems, Other Detection & Prediction Device Types) Market by End-user (Hospitals & Clinics, Neurology Centers, Home Care Settings, Other End-users) by Geography

Request free sample

In terms of revenue, the global epilepsy devices market was valued at $611.26 million in 2021, and is expected to reach $1203.70 million by 2030, growing at a CAGR of 7.83% during the forecast period.

Recurrent seizures are a defining feature of the chronic, non-communicable brain disorder epilepsy, which affects people of all ages and involves brief episodes of uncontrollable movement of the entire body or a specific region of the body. Sometimes, seizures are also followed by unconsciousness and loss of control over urination or bowel movements. The International League Against Epilepsy (ILAE) classifies epilepsy as one of the following criteria being present in a person:

  • At least two reflex or spontaneous seizures occur over 24 hours apart.
  • One spontaneous (or reflex) seizure, followed over the following ten years by a chance of additional seizures equal to the general reoccurring danger of at least 60%.
  • Diagnosis of an epileptic condition – Epilepsy is regarded as resolved in people with epilepsy syndrome, which is age-dependent but is now older than the appropriate age or in individuals who have lived 10 years without experiencing a seizure and have not taken seizure medications for that time.

According to the World Health Organization, epilepsy affects about 50 million people globally and makes up a sizable share of the global disease burden. According to estimates, epilepsy affects 49 out of every 100,000 people in high-income nations. This number can reach 139 per 100,000 in low and middle-income nations. With the right diagnosis and the use of affordable, widely accessible anti-seizure medications, approximately 70% of patients with epilepsy could be cured of their seizures.

Epilepsy Devices Market

Read our latest blog on the Epilepsy Devices Market

Key growth enablers for the global epilepsy devices market are:

  • Soaring occurrences of epilepsy globally
  • Onset of epilepsy in elderly people
    • The interaction between aging, epilepsy, and dementia has grown more crucial as the world’s population ages, and older people have the highest incidence and prevalence of epilepsy.
    • After crossing 60, seizures become more common and are frequently brought on by other neurological diseases like dementia or stroke.
    • In addition, seniors have more difficulty managing their epilepsy than younger patients since they are more likely to have comorbid conditions and need concurrent therapies.
    • In order to maintain quality of life during old age, early detection and treatment of epilepsy in the elderly are extremely important. This will consequently serve as a driver for the expansion of the epileptic devices market.
  • Mitigation of epilepsy using early diagnosis
  • Surge in post-traumatic epilepsy with rising brain injury cases

Key growth restraining factors are:

  • Misperceptions and misinformation about epilepsy
    • Misunderstandings regarding epilepsy and seizures have persisted for generations, resulting in prejudice and discrimination against those who suffer from them.
    • In addition to the anxiety of having to watch and cope with a seizure, discrimination against people with this disease is motivated by the false belief that the patient is impotent, frail, and mentally impaired.
    • The prevention, early treatment, and community compliance with modern therapy depend on the public’s understanding of a medical condition. Its absence in epilepsy likely contributes to the significant treatment gap seen in many developing countries and is, therefore, a restraining factor for the growth of the studied market.
  • Shortage of neurology specialists in the healthcare system

Global Epilepsy Devices Market | Top Trends

  • Cutting-edge new advances in this industry include the debut of several wearable gadgets that can track seizures, record data, and inform caretakers. Direct seizure activity measurement may be possible using minimally invasive subscale electroencephalography (EEG) and non-invasive scalp EEG.
  • Telemedicine services, especially those that enable the interactive exchange of information between patients and doctors, are one of the top trends as it helps assist remote healthcare for those with epilepsy.
  • The bulk of antiepileptic drugs (AED) have been created to meet regulatory requirements, and often they feature stringent eligibility restrictions, tight dosing schemes, brief follow-up times, and comparisons with placebos rather than currently researched conventional treatments.

To know more about this report, request a free sample copy

Market Segmentation – Product Type, Technology, Detection & Prediction Devices Type, and End-User –

Market by Product Type:

  • Conventional Devices
  • Wearable Devices
    • Watches
    • Bracelets
    • Camera Devices
    • Mattress Devices
    • Anti-Suffocation Pillows
    • Other Wearable Devices
  • Implantable Devices

Market by Technology:

  • Vagus Nerve Stimulation
    • The United States Food and Drug Administration (FDA) has approved vagus nerve stimulation (VNS Therapy®) as an add-on therapy for adults and children aged 4 and up.
    • Although VNS therapy seldom results in complete seizure independence, it may help lower seizure frequency and enhance the quality of life.
    • A wide spectrum of patients, including those with post-traumatic epilepsy, have reportedly benefited from VNS (PTE). PTE, which accounts for 20% of symptomatic epilepsy, is a frequent result of traumatic brain damage. These patients may not have a localizable lesion and are frequently resistant to antiepileptic drug therapy.
  • Deep Brain Stimulation
    • Movement Disorders
    • Epilepsy
  • Accelerometry
  • Responsive Neurostimulation

Market by Detection & Prediction Devices Type:

  • Electroencephalogram
    • Electroencephalography (EEG) is a crucial tool in diagnosing epilepsy because it enables the detection of epileptiform activity, which aids in syndromic diagnosis and classification.
    • The typical scalp EEG solution used in hospitals is expensive, time-consuming, uncomfortable for patients, and takes the patient out of their home setting.
    • New wearable or mobile EEG technologies that enable long-term EEG monitoring in an intuitive style with acceptable performance compared to conventional EEG are gaining popularity.
    • Recent studies are testing and evaluating the viability and acceptability of non-invasive devices in the hospital and home, enhancing seizure detection accuracy.
  • Intracranial EEG
  • Surface Electromyography
  • Electrocardiography
  • Video Detection Systems
  • Electrodermal Activity
  • Implanted Advisory Systems
  • Other Detection & Prediction Device Types

Market by End-User:

  • Hospitals & Clinics
  • Neurology Centres
  • Home Care Settings
  • Other End-Users

 

Geographical Study based on Four Major Regions:

  • North America: The United States and Canada
  • Europe: The United Kingdom, Germany, France, Italy, Spain, Nordic Countries, and Rest of Europe
  • Asia-Pacific: China, Japan, India, South Korea, Indonesia, Singapore, Taiwan, Australia & New Zealand, and Rest of Asia-Pacific
    • Due to the rapid improvement in healthcare spending, particularly in countries like China and India, as well as the rise of medical tourism and higher healthcare expenditure in this region, the Asia-Pacific is predicted to be the most active regional market.
    • In addition, the market is being driven by the region’s large senior population. In a report published in June 2019 by Seoul National University Hospital in South Korea, epilepsy was listed as the third most prevalent neurological condition in older persons after dementia and stroke.
    • The Japanese government favors telemedicine legislation, pharmaceutical and surgical therapies improvements, and the quick development of genetic, metabolic, and neuroimaging techniques, increasing demand for epilepsy equipment.
    • The All-India Institute of Medical Sciences (AIIMS), Rishikesh, and the Indian Institute of Science (IISc) created an algorithm in September 2022 that, according to the researchers, can help study human brain scans to evaluate the presence and kind of epilepsy. The algorithm is currently being tested for dependability by doctors at AIIMS Rishikesh, along with an application for a patent for the work.
  • Rest of World: Latin America, the Middle East & Africa

The major players in the global epilepsy devices market are

  • Nihon Kohden Corporation
  • Medtronic PLC
  • Compumedics Limited
  • Koninklijke Philips NV
  • Natus Medical Incorporated

Key strategies adopted by some of these companies:

Medtronic PLC acquired Affera Inc in August 2022 to expand its cardiac ablation portfolio to include its first cardiac mapping and navigation platform, consisting of a focal pulsed field and radiofrequency ablation solution that is distinct and fully integrated.

Ambulatory Surgery Centers (ASCs) and Office Based Labs (OBLs) have special needs and demand for care. In April 2022, Medtronic and GE Healthcare announced an alliance to handle these needs and demands, enabling customers to access a wide range of financial solutions, product portfolios, and great service.

The Boston Scientific Corporation’s EMBOLDTM Fibered Detachable Coil, designed to restrict or slow blood circulation in the peripheral vasculature, was given 510(k) clearance by U.S. Food and Drug Administration (FDA) in April 2022.

In August 2021, NeuroPace Inc announced the release of its online platform named nSight platform, which enables doctors to remotely review patient progress, find useful insights, and monitor their clinic’s overall patient outcomes. This portal enables doctors to provide more customized, data-driven epilepsy care.

Report Synopsis:

Report Scope

Details
Market Forecast Years 2022-2030
Base Year 2021
Market Historical Years 2018-2021
Forecast Units Revenue ($ Million)
Segments Analyzed Product Type, Technology, Detection & Prediction Devices Type, End-User
Geographies Analyzed North America, Europe, Asia-Pacific, Rest of World
Companies Analyzed

Boston Scientific Corporation, Cadwell Industries Inc, Compumedics Limited, Drägerwerk AG & Co KGaA, Empatica Inc, Koninklijke Philips NV, LivaNova PLC, Medtronic PLC, Natus Medical Incorporated, Nihon Kohden Corporation, NeuroPace Inc, Neurosoft, Shenzhen Mindray Bio-Medical Electronics Co Ltd

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • KEY DRIVERS
      • SOARING OCCURRENCES OF EPILEPSY GLOBALLY
      • ONSET OF EPILEPSY IN ELDERLY PEOPLE
      • MITIGATION OF EPILEPSY USING EARLY DIAGNOSIS
      • SURGE IN POST-TRAUMATIC EPILEPSY WITH RISING BRAIN INJURY CASES
    • KEY RESTRAINTS
      • MISPERCEPTIONS AND MISINFORMATION ABOUT EPILEPSY
      • SHORTAGE OF NEUROLOGY SPECIALISTS IN THE HEALTHCARE SYSTEM
  1. KEY ANALYTICS
    • IMPACT OF COVID-19 ON EPILEPSY DEVICES MARKET
    • KEY MARKET TRENDS
    • PORTER’S FIVE FORCES ANALYSIS
      • BUYERS POWER
      • SUPPLIERS POWER
      • SUBSTITUTION
      • NEW ENTRANTS
      • INDUSTRY RIVALRY
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    • VALUE CHAIN ANALYSIS
    • KEY BUYING CRITERIA
      • COMFORT & USABILITY
      • PRODUCT FEATURES
      • CONFIDENTIALITY
    • REGULATORY FRAMEWORK
  2. MARKET BY PRODUCT TYPE
    • CONVENTIONAL DEVICES
    • WEARABLE DEVICES
      • WATCHES
      • BRACELETS
      • CAMERA DEVICES
      • MATTRESS DEVICES
      • ANTI-SUFFOCATION PILLOWS
      • OTHER WEARABLE DEVICES
    • IMPLANTABLE DEVICES
  3. MARKET BY TECHNOLOGY
    • VAGUS NERVE STIMULATION
    • DEEP BRAIN STIMULATION
      • MOVEMENT DISORDERS
      • EPILEPSY
    • ACCELEROMETRY
    • RESPONSIVE NEUROSTIMULATION
  4. MARKET BY DETECTION & PREDICTION DEVICES TYPE
    • ELECTROENCEPHALOGRAM
    • INTRACRANIAL EEG
    • SURFACE ELECTROMYOGRAPHY
    • ELECTROCARDIOGRAPHY
    • VIDEO DETECTION SYSTEMS
    • ELECTRODERMAL ACTIVITY
    • IMPLANTED ADVISORY SYSTEMS
    • OTHER DETECTION & PREDICTION DEVICE TYPES
  5. MARKET BY END-USER
    • HOSPITALS & CLINICS
    • NEUROLOGY CENTERS
    • HOME CARE SETTINGS
    • OTHER END-USERS
  6. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED KINGDOM
        • GERMANY
        • FRANCE
        • ITALY
        • SPAIN
        • NORDIC COUNTRIES
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET ESTIMATES & SIZES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • SOUTH KOREA
        • INDONESIA
        • SINGAPORE
        • TAIWAN
        • AUSTRALIA & NEW ZEALAND
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • MARKET ESTIMATES & SIZES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA
  1. COMPETITIVE LANDSCAPE
    • KEY STRATEGIC DEVELOPMENTS
      • ACQUISITIONS
      • PRODUCT LAUNCHES & DEVELOPMENTS
      • PARTNERSHIPS
    • COMPANY PROFILES
      • BOSTON SCIENTIFIC CORPORATION
      • CADWELL INDUSTRIES INC
      • COMPUMEDICS LIMITED
      • DRÄGERWERK AG & CO KGAA
      • EMPATICA INC
      • KONINKLIJKE PHILIPS NV
      • LIVANOVA PLC
      • MEDTRONIC PLC
      • NATUS MEDICAL INCORPORATED
      • NEUROPACE INC
      • NEUROSOFT
      • NIHON KOHDEN CORPORATION
      • SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD

LIST OF TABLES  

TABLE 1: MARKET SNAPSHOT – EPILEPSY DEVICES

TABLE 2: EXAMPLES OF ANTIEPILEPTIC DRUGS FOR THE ELDERLY AND THEIR ADVANTAGES

TABLE 3: EXAMPLES OF MOBILE EEG DEVICES

TABLE 4: REGULATORY FRAMEWORK

TABLE 5: GLOBAL EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 6: GLOBAL EPILEPSY DEVICES MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 7: GLOBAL CONVENTIONAL DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 8: GLOBAL CONVENTIONAL DEVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 9: GLOBAL WEARABLE DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 10: GLOBAL WEARABLE DEVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 11: GLOBAL EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 12: GLOBAL EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 13: GLOBAL WATCHES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 14: GLOBAL WATCHES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 15: GLOBAL BRACELETS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 16: GLOBAL BRACELETS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 17: GLOBAL CAMERA DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 18: GLOBAL CAMERA DEVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 19: GLOBAL MATTRESS DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 20: GLOBAL MATTRESS DEVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 21: GLOBAL ANTI-SUFFOCATION PILLOWS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 22: GLOBAL ANTI-SUFFOCATION PILLOWS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 23: GLOBAL OTHER WEARABLE DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 24: GLOBAL OTHER WEARABLE DEVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 25: GLOBAL IMPLANTABLE DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 26: GLOBAL IMPLANTABLE DEVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 27: GLOBAL EPILEPSY DEVICES MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 28: GLOBAL EPILEPSY DEVICES MARKET, BY TECHNOLOGY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 29: GLOBAL VAGUS NERVE STIMULATION MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 30: GLOBAL VAGUS NERVE STIMULATION MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 31: GLOBAL DEEP BRAIN STIMULATION MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 32: GLOBAL DEEP BRAIN STIMULATION MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 33: GLOBAL EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 34: GLOBAL EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 35: GLOBAL MOVEMENT DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 36: GLOBAL MOVEMENT DISORDERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 37: GLOBAL EPILEPSY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 38: GLOBAL EPILEPSY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 39: GLOBAL ACCELEROMETRY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 40: GLOBAL ACCELEROMETRY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 41: GLOBAL RESPONSIVE NEUROSTIMULATION MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 42: GLOBAL RESPONSIVE NEUROSTIMULATION MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 43: GLOBAL EPILEPSY DEVICES MARKET, BY DETECTION & PREDICTION DEVICES TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 44: GLOBAL EPILEPSY DEVICES MARKET, BY DETECTION & PREDICTION DEVICES TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 45: GLOBAL ELECTROENCEPHALOGRAM MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 46: GLOBAL ELECTROENCEPHALOGRAM MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 47: GLOBAL INTRACRANIAL EEG MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 48: GLOBAL INTRACRANIAL EEG MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 49: GLOBAL SURFACE ELECTROMYOGRAPHY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 50: GLOBAL SURFACE ELECTROMYOGRAPHY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 51: GLOBAL ELECTROCARDIOGRAPHY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 52: GLOBAL ELECTROCARDIOGRAPHY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 53: GLOBAL VIDEO DETECTION SYSTEMS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 54: GLOBAL VIDEO DETECTION SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 55: GLOBAL ELECTRODERMAL ACTIVITY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 56: GLOBAL ELECTRODERMAL ACTIVITY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 57: GLOBAL IMPLANTED ADVISORY SYSTEMS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 58: GLOBAL IMPLANTED ADVISORY SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 59: GLOBAL OTHER DETECTION & PREDICTION DEVICE TYPES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 60: GLOBAL OTHER DETECTION & PREDICTION DEVICE TYPES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 61: GLOBAL EPILEPSY DEVICES MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 62: GLOBAL EPILEPSY DEVICES MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 63: GLOBAL HOSPITALS & CLINICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 64: GLOBAL HOSPITALS & CLINICS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 65: GLOBAL NEUROLOGY CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 66: GLOBAL NEUROLOGY CENTERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 67: GLOBAL HOME CARE SETTINGS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 68: GLOBAL HOME CARE SETTINGS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 69: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 70: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 71: GLOBAL EPILEPSY DEVICES MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 72: GLOBAL EPILEPSY DEVICES MARKET, BY GEOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 73: NORTH AMERICA EPILEPSY DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 74: NORTH AMERICA EPILEPSY DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 75: LEADING PLAYERS OPERATING IN NORTH AMERICA EPILEPSY DEVICES MARKET

TABLE 76: EUROPE EPILEPSY DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 77: EUROPE EPILEPSY DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 78: LEADING PLAYERS OPERATING IN EUROPE EPILEPSY DEVICES MARKET

TABLE 79: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 80: ASIA-PACIFIC EPILEPSY DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 81: LEADING PLAYERS OPERATING IN ASIA-PACIFIC EPILEPSY DEVICES MARKET

TABLE 82: REST OF WORLD EPILEPSY DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 83: REST OF WORLD EPILEPSY DEVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 84: LEADING PLAYERS OPERATING IN REST OF WORLD EPILEPSY DEVICES MARKET

TABLE 85: LIST OF ACQUISITIONS

TABLE 86: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 87: LIST OF PARTNERSHIPS

LIST OF FIGURES 

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: VALUE CHAIN ANALYSIS

FIGURE 6: KEY BUYING CRITERIA

FIGURE 7: GLOBAL EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2021

FIGURE 8: GLOBAL EPILEPSY DEVICES MARKET, BY CONVENTIONAL DEVICES, 2022-2030 (IN $ MILLION)

FIGURE 9: GLOBAL EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2022-2030 (IN $ MILLION)

FIGURE 10: GLOBAL EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY WEARABLE DEVICES, IN 2021

FIGURE 11: GLOBAL EPILEPSY DEVICES MARKET, BY WATCHES, 2022-2030 (IN $ MILLION)

FIGURE 12: GLOBAL EPILEPSY DEVICES MARKET, BY BRACELETS, 2022-2030 (IN $ MILLION)

FIGURE 13: GLOBAL EPILEPSY DEVICES MARKET, BY CAMERA DEVICES, 2022-2030 (IN $ MILLION)

FIGURE 14: GLOBAL EPILEPSY DEVICES MARKET, BY MATTRESS DEVICES, 2022-2030 (IN $ MILLION)

FIGURE 15: GLOBAL EPILEPSY DEVICES MARKET, BY ANTI-SUFFOCATION PILLOWS, 2022-2030 (IN $ MILLION)

FIGURE 16: GLOBAL EPILEPSY DEVICES MARKET, BY OTHER WEARABLE DEVICES, 2022-2030 (IN $ MILLION)

FIGURE 17: GLOBAL EPILEPSY DEVICES MARKET, BY IMPLANTABLE DEVICES, 2022-2030 (IN $ MILLION)

FIGURE 18: GLOBAL EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2021

FIGURE 19: GLOBAL EPILEPSY DEVICES MARKET, BY VAGUS NERVE STIMULATION, 2022-2030 (IN $ MILLION)

FIGURE 20: GLOBAL EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2030 (IN $ MILLION)

FIGURE 21: GLOBAL EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY DEEP BRAIN STIMULATION, IN 2021

FIGURE 22: GLOBAL EPILEPSY DEVICES MARKET, BY MOVEMENT DISORDERS, 2022-2030 (IN $ MILLION)

FIGURE 23: GLOBAL EPILEPSY DEVICES MARKET, BY EPILEPSY, 2022-2030 (IN $ MILLION)

FIGURE 24: GLOBAL EPILEPSY DEVICES MARKET, BY ACCELEROMETRY, 2022-2030 (IN $ MILLION)

FIGURE 25: GLOBAL EPILEPSY DEVICES MARKET, BY RESPONSIVE NEUROSTIMULATION, 2022-2030 (IN $ MILLION)

FIGURE 26: GLOBAL EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY DETECTION & PREDICTION DEVICES TYPE, IN 2021

FIGURE 27: GLOBAL EPILEPSY DEVICES MARKET, BY ELECTROENCEPHALOGRAM, 2022-2030 (IN $ MILLION)

FIGURE 28: GLOBAL EPILEPSY DEVICES MARKET, BY INTRACRANIAL EEG, 2022-2030 (IN $ MILLION)

FIGURE 29: GLOBAL EPILEPSY DEVICES MARKET, BY SURFACE ELECTROMYOGRAPHY, 2022-2030 (IN $ MILLION)

FIGURE 30: GLOBAL EPILEPSY DEVICES MARKET, BY ELECTROCARDIOGRAPHY, 2022-2030 (IN $ MILLION)

FIGURE 31: GLOBAL EPILEPSY DEVICES MARKET, BY VIDEO DETECTION SYSTEMS, 2022-2030 (IN $ MILLION)

FIGURE 32: GLOBAL EPILEPSY DEVICES MARKET, BY ELECTRODERMAL ACTIVITY, 2022-2030 (IN $ MILLION)

FIGURE 33: GLOBAL EPILEPSY DEVICES MARKET, BY IMPLANTED ADVISORY SYSTEMS, 2022-2030 (IN $ MILLION)

FIGURE 34: GLOBAL EPILEPSY DEVICES MARKET, BY OTHER DETECTION & PREDICTION DEVICE TYPES, 2022-2030 (IN $ MILLION)

FIGURE 35: GLOBAL EPILEPSY DEVICES MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021

FIGURE 36: GLOBAL EPILEPSY DEVICES MARKET, BY HOSPITALS & CLINICS, 2022-2030 (IN $ MILLION)

FIGURE 37: GLOBAL EPILEPSY DEVICES MARKET, BY NEUROLOGY CENTERS, 2022-2030 (IN $ MILLION)

FIGURE 38: GLOBAL EPILEPSY DEVICES MARKET, BY HOME CARE SETTINGS, 2022-2030 (IN $ MILLION)

FIGURE 39: GLOBAL EPILEPSY DEVICES MARKET, BY OTHER END-USERS, 2022-2030 (IN $ MILLION)

FIGURE 40: NORTH AMERICA EPILEPSY DEVICES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 41: UNITED STATES EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 42: CANADA EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 43: EUROPE EPILEPSY DEVICES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 44: UNITED KINGDOM EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 45: GERMANY EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 46: FRANCE EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 47: ITALY EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 48: SPAIN EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 49: NORDIC COUNTRIES EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 50: REST OF EUROPE EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 51: ASIA-PACIFIC EPILEPSY DEVICES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN%)

FIGURE 52: CHINA EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 53: JAPAN EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 54: INDIA EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 55: SOUTH KOREA EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 56: INDONESIA EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 57: SINGAPORE EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 58: TAIWAN EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 59: AUSTRALIA & NEW ZEALAND EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 60: REST OF ASIA-PACIFIC EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 61: REST OF WORLD EPILEPSY DEVICES MARKET, REGIONAL OUTLOOK, 2021 & 2030 (IN %)

FIGURE 62: LATIN AMERICA EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 63: MIDDLE EAST & AFRICA EPILEPSY DEVICES MARKET, 2022-2030 (IN $ MILLION)

  1. MARKET BY PRODUCT TYPE
    • CONVENTIONAL DEVICES
    • WEARABLE DEVICES
      • WATCHES
      • BRACELETS
      • CAMERA DEVICES
      • MATTRESS DEVICES
      • ANTI-SUFFOCATION PILLOWS
      • OTHER WEARABLE DEVICES
    • IMPLANTABLE DEVICES
  2. MARKET BY TECHNOLOGY
    • VAGUS NERVE STIMULATION
    • DEEP BRAIN STIMULATION
      • MOVEMENT DISORDERS
      • EPILEPSY
    • ACCELEROMETRY
    • RESPONSIVE NEUROSTIMULATION
  3. MARKET BY DETECTION & PREDICTION DEVICES TYPE
    • ELECTROENCEPHALOGRAM
    • INTRACRANIAL EEG
    • SURFACE ELECTROMYOGRAPHY
    • ELECTROCARDIOGRAPHY
    • VIDEO DETECTION SYSTEMS
    • ELECTRODERMAL ACTIVITY
    • IMPLANTED ADVISORY SYSTEMS
    • OTHER DETECTION & PREDICTION DEVICE TYPES
  4. MARKET BY END-USER
    • HOSPITALS & CLINICS
    • NEUROLOGY CENTERS
    • HOME CARE SETTINGS
    • OTHER END-USERS
  5. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED KINGDOM
        • GERMANY
        • FRANCE
        • ITALY
        • SPAIN
        • NORDIC COUNTRIES
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET ESTIMATES & SIZES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • SOUTH KOREA
        • INDONESIA
        • SINGAPORE
        • TAIWAN
        • AUSTRALIA & NEW ZEALAND
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • MARKET ESTIMATES & SIZES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    Frequently Asked Questions (FAQs):

    Which country has the highest growth potential by 2030 in the Asia-Pacific epilepsy devices market?

    India has the highest growth potential by 2030 in the Asia-Pacific epilepsy devices market.

    Which segment will be driving the demand for the global epilepsy devices market?

    Electroencephalograms in epilepsy detection and prediction devices type will drive the demand for the epilepsy devices market.

    What notable key trends in the global epilepsy devices market?

    Rise in wearable devices capable of detecting seizures, recording seizure data, and alerting caregivers is one of the notable trends in the global epilepsy devices market.

    To request a free sample copy of this report, please complete the form below:

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type